Tonix Pharm Holdings (TNXP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -77,111 | -45,101 | -16,829 | -130,036 | -107,928 |
| Depreciation Amortization | 1,502 | 1,041 | 558 | 4,261 | 3,565 |
| Accounts receivable | 170 | 1,363 | 371 | -3,683 | -4,982 |
| Accounts payable and accrued liabilities | 3,732 | 2,711 | -353 | 927 | 346 |
| Other Working Capital | 4,750 | 4,134 | -3,282 | 5,775 | -641 |
| Other Operating Activity | 6,763 | 4,440 | 2,956 | 61,831 | 63,345 |
| Operating Cash Flow | $-60,194 | $-31,412 | $-16,579 | $-60,925 | $-46,295 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -2,012 | N/A | N/A | N/A | N/A |
| PPE Investments | -1,495 | -533 | -6 | -120 | -117 |
| Other Investing Activity | 0 | -2,012 | 0 | 0 | 0 |
| Investing Cash Flow | $-3,507 | $-2,545 | $-6 | $-120 | $-117 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 170,986 | 76,125 | 62,230 | 140,222 | 54,363 |
| Common Stock Repurchased | -5,949 | -5,949 | -3,047 | N/A | N/A |
| Other Financing Activity | -9,650 | -9,650 | -9,650 | -5,350 | -4,645 |
| Financing Cash Flow | $155,387 | $60,526 | $49,533 | $134,872 | $49,718 |
| Exchange Rate Effect | -17 | -13 | -9 | 4 | -20 |
| Beginning Cash Position | 99,680 | 99,680 | 99,680 | 25,849 | 25,850 |
| End Cash Position | 191,349 | 126,236 | 132,619 | 99,680 | 29,136 |
| Net Cash Flow | $91,669 | $26,556 | $32,939 | $73,831 | $3,286 |
| Free Cash Flow | |||||
| Operating Cash Flow | -60,194 | -31,412 | -16,579 | -60,925 | -46,295 |
| Capital Expenditure | -1,495 | -533 | -6 | -120 | -117 |
| Free Cash Flow | -61,689 | -31,945 | -16,585 | -61,045 | -46,412 |